# Evaluation of the Hypolipidemic Effect of Bergavit by a Human Trial.

> **NCT06692777** · NA · COMPLETED · sponsor: **Chung Shan Medical University** · enrollment: 120 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DIETARY_SUPPLEMENT:** Bergavit
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06692777
- **Lead sponsor:** Chung Shan Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-21
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06692777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06692777, "Evaluation of the Hypolipidemic Effect of Bergavit by a Human Trial.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06692777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*